Sure-Screen Amphetamine, Benzodiazepine, Cocaine, Methamphetamine/Mdma, Methadone, Opiates, Phencyclidine & Cannabinoids
Enzyme Immunoassay, Amphetamine. 510(k) K050394, from Medtox Diagnostics, Inc. (Burlington, NC). Product code DKZ, class 2.
As of Nov 21, 2026, K050394 is an FDA 510(k) held by Medtox Diagnostics, Inc., substantially equivalent on Oct 25, 2005 after 251 days, with no recalls tied to it in FDA's recall database.
- Review time: 251 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The SURE-SCREEN Drugs of Abuse Test System uses immunochromatographic test strips for the rapid, qualitative detection of one or more of the following: Amphetamines, Benzodiazepines, Cocaine, Methamphetamine, Methadone, Opiates, Phencyclidine and THC (Cannabinoids) in human urine.
- Wondfo Oxazepam Urine Test (Bzo 200) and Wondfo Methamphetamine Urine Test (Met 300)K132630 · Guangzhou Wondfo Biotech Co., Ltd. · Sep 27, 2013
- Wondfo Cocaine Urine Test (Coc 100), Wondfo Cannabinoids Urine Test (Thc 40)K131754 · Guangzhou Wondfo Biotech Co., Ltd. · Jul 31, 2013
- Wondfo Methadone Urine Test (Mtd 200), Wondofo Morphine Urine Test (Mop 100)K131232 · Guangzhou Wondfo Biotech Co., Ltd. · May 31, 2013
- DRI Ecstasy Plus AssayK240670 · Microgenics Corporation · Oct 30, 2024
- AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest…K233019 · Hangzhou AllTest Biotech Co., Ltd. · Dec 13, 2023
- Xenta Drug Screen Cup, Xenta Drug Screen DipcardK231137 · Xenta Biomedical Science Co., Ltd. · May 19, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 16, 2005
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files